This approval will enable significant improvements in Ruconest s competitiveness and will allow Pharming
to meet future global demands with a secure supply chain agreement on the long term for the treatment of HAE as well as follow-up indications.
The acquisition of DNage will provide Pharming
with access to highly innovative products and a technology platform for new markets in the areas of ageing and cancer," said Dr.
has obtained access to processes and know-how for the large scale GMP grade purification of recombinant fibrinogen.
Santarus and Pharming
caution you that statements included in this press release that are not a description of historical facts are forward-looking statements.
has submitted orphan drug applications with rhC1INH for specific new indications beyond HAE.
In 1998, Pharming
formed a joint venture with Genzyme for the development and commercialization of transgenic human alpha-Glucosidase for Pompe's disease.
In recent years, pharming
has become a major concern to businesses hosting ecommerce and online banking websites.
RUCONEST is commercialized by Pharming
in Austria, Germany and The Netherlands.
Sijmen de Vries, Pharming
s CEO commented: With this second tranche of our equity working capital facility we would expect to be able to complete Study 1310 and analyse the primary endpoint results.
Under the terms of the agreement, Pharming
has received an upfront payment of US $18.
attacks are a growing crime that is invisible to victims, but easy to protect against with the Catbird Anti-Pharming
has a unique GMP compliant, validated platform for the production of recombinant human proteins that has proven capable of producing industrial volumes of high quality recombinant human protein in a more economical way compared to current cell-based technologies.